#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Spina bifida in the Czech Republic – incidence and prenatal dia­gnostics


Authors: A. Šípek 1-4;  V. Gregor 1,3;  A. Šípek jr. 1,5;  N. Friedová 5;  J. Klaschka 6,7;  M. Malý 6,8;  J. Jírová 9
Authors‘ workplace: Oddělení lékařské genetiky, Thomayerova nemocnice, Praha 1;  Oddělení lékařské genetiky, Gennet, Praha 2;  Oddělení lékařské genetiky, Sanatorium Pronatal, Praha 3;  Ústav lékařské genetiky, 3. LF UK, Praha 4;  Ústav biologie a lékařské genetiky, 1. LF UK a VFN v Praze 5;  Ústav informatiky, AV ČR, Praha 6;  Ústav biofyziky a informatiky 1. LF UK, Praha 7;  Státní zdravotní ústav, Praha 8;  Ústav zdravotnických informací, a statistiky, ČR, Praha 9
Published in: Cesk Slov Neurol N 2019; 82(4): 410-414
Category: Original Paper
doi: https://doi.org/10.14735/amcsnn2019410

Overview

Aim: Retrospective epidemiological analysis of the incidence and prenatal dia­gnosis of spina bifida in the Czech Republic from 1994–2015 taken from the databases of the National Registry of Congenital Defects (NRVV) and data from the Czech Society of Medical Genetics and Genomics.

Materials and methods: We used the data from the NRVV kept in the Register of Reproductive Health at the Institute of Health Information and Statistics of Czech Republic from 1994–2015. The second source were data on prenatal dia­gnosis collected under the guidance of the Czech Society of Medical Genetics and Genomics. In our work, we analyzed the annual frequencies and their changes in both born children and prenatally-dia­gnosed cases. We also analyzed weeks of pregnancy in prenatally-dia­gnosed cases.

Results: From 1994–2015, 981 cases of spina bifida were dia­gnosed. Prenatally-dia­gnosed spina bifida and pregnancies that were prematurely terminated included 635 cases, while 346 cases were detected in infants. In relative numbers, the overall incidence rate was 4.36, the incidence of prenatally-dia­gnosed cases was 2.82, and 1.54 in newborns (per 10,000 live births). The effectiveness of prenatal dia­gnosis (P < 0.001) and the incidence of prenatally-dia­gnosed cases (P < 0.001) increased significantly. At the same time, there was a statistically significant decrease in the incidence in newborns (P < 0.001). Both of these trends went against each other, therefore the overall trend was not statistically significant (P = 0.082). There was no change in the pregnancy week during prenatal dia­gnosis.

Conclusion: Due to the successful prenatal dia­gnosis, there was a statically significant decrease in the dia­gnosis of spina bifida in children born during the observed period.

The authors declare they have no potential conflicts of interest concerning drugs, products, or services used in the study.

The Editorial Board declares that the manuscript met the ICMJE “uniform requirements” for biomedical papers.


捷克共和国的脊柱裂–发病率和产前诊断

目的:捷克共和国1994-2015年脊柱裂发病率和产前诊断的回顾性流行病学分析,来自国家先天性缺陷登记处(NRVV)数据库和捷克医学遗传学和基因组学学会的数据。

材料和方法:我们使用了1994-2015年捷克共和国卫生信息与统计研究所生殖健康登记册中保存的NRVV数据。第二个来源是在捷克医学遗传学和基因组学学会的指导下收集的产前诊断数据。在我们的工作中,我们分析了出生儿童和产前诊断病例的年度频率及其变化。我们还分析了产前诊断病例的怀孕几周。

结果:从1994年至2015年,诊断出981例脊柱裂。产前诊断的脊柱裂和早产终止包括635例,而婴儿中检出346例。相对而言,总发病率为4.36,产前诊断病例的发病率为2.82,新生儿(每10,000活产婴儿)为1.54。产前诊断的有效性(P <0.001)和产前诊断病例的发生率(P <0.001)显着增加。同时,新生儿的发生率有统计学上的显着下降(P <0.001)。这两个趋势相互矛盾,因此总体趋势在统计上并不显着(P = 0.082)。产前诊断期间,怀孕周没有变化。

结论:由于成功的产前诊断,在此期间出生的儿童中脊柱裂的诊断静态减少。

关键词:神经管缺陷–先天性异常–捷克共和国

Keywords:

Czech Republic – neural tube defects – congenital abnormalities


Sources

1. Greene ND, Copp AJ. Neural tube defects. Annu Rev Neurosci 2014; 37: 221–242. doi: 10.1146/ annurev-neuro-062012-170354.

2. Copp AJ, Greene ND. Genetics and development of neural tube defects. J Pathol 2010; 220(2): 217–230. doi: 10.1002/ path.2643.

3. Au KS, Ashley-Koch A, Northrup H. Epidemiologic and genetic aspects of spina bifida and other neural tube defects. Dev Disabil Res Rev 2010; 16(1): 6–15. doi: 10.1002/ ddrr.93.

4. Copp AJ, Stanier P, Greene ND. Neural tube defects: recent advances, unsolved questions, and controversies. Lancet Neurol 2013; 12(8): 799–810. doi: 10.1016/ S1474-4422(13)70110-8.

5. Fletcher JM, Brei TJ. Spina bifida – a multidisciplinary perspective. Dev Disabil Res Rev 2010; 16(1): 1–5. doi: 10.1002/ ddrr.101.

6. Mohd-Zin SW, Marwan AI, Abou Chaar MK et al. Spina bifida: pathogenesis, mechanisms, and genes in mice and humans. Scientifica (Cairo) 2017; 2017: 5364827. doi: 10.1155/ 2017/ 5364827.

7. Coleman BG, Langer JE, Horii SC. The dia­gnostic features of spina bifida: the role of ultrasound. Fetal Dia­gn
Ther 2015; 37(3): 179–196. doi: 10.1159/ 000364806.

8. Loucký J, Springer D, Šubrt I. Doporučení o laboratorním screeningu vrozených vývojových vad v prvním a druhém trimestru těhotenství. Klin Biochem Metab 2015; 23(44): 27–30.

9. Hardin JW, Hilbe JM. Generalized linear models and extensions. 4th ed. College Station: A Stata Press Publication 2012.

10. Šípek A, Gregor V, Horáček J et al. National Registry of Congenital Anomalies of the Czech Republic: commemorating 50 years of the official registration. Cent Eur J Public Health 2014; 22(4): 287–288. doi: 10.21101/ cejph.a4201.

11. Gregor V, Šípek A, Horáček J et al. Týden těhotenství při prenatální dia­gnostice vrozených vad v České republice, 1996–2002. Česká Gynekol 2004; 69 (Suppl 1): 53–59.

12. Gregor V, Šípek A, Horáček J et al. Vliv prenatální dia­gnostiky na četnosti vrozených vad v České republice v roce 2004. Česká Gynekol 2006; 71(5): 373–380.

13. Šípek A, Gregor V, Šípek A Jr et al. Vrozené vady v České republice v období 1994–2007. Česká Gynekol 2009; 74(1): 31–44.

14. Gregor V, Šípek A Jr, Horáček J et al. Prenatální dia­gnostika vrozených vad v České republice – patnáctileté období. Česká Gynekol 2012; 77(5): 437–444.

15. The International Centre on Birth Defects – ICBDSR Centre. Annual Report – 2014. Rome 2015: 208. [online]. Available from URL: http: / / www.icbdsr.org/ wp-content/ annual_report/ Report2014.pdf.

16. Šípek A, Gregor V, Horáček J et al. Incidence vybraných vrozených vad v České republice. Vrozené vady centrálního nervového systému a gastrointestinálního traktu. Epidemiol Mikrobio­l Imunol 2015; 64(1): 47–53.

17. Botto LD, Lisi A, Bower C et al. Trends of selected malformations in relation to folic acid recommendations and fortification. Birth Defects Res A Clin Mol Teratol 2006; 76(10): 693–705. doi: 10.1002/ bdra.20307.

18. Šípek A Jr, Gregor V, Šípek A et al. Primární prevence vrozených vad a úloha kyseliny listové. Actual Gyn 2013; 5: 47–51.

Labels
Paediatric neurology Neurosurgery Neurology

Article was published in

Czech and Slovak Neurology and Neurosurgery

Issue 4

2019 Issue 4

Most read in this issue
Login
Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account

#ADS_BOTTOM_SCRIPTS#